The wearable technology sector is undergoing a structural shift. For years, the industry focused on hardware innovation—smaller sensors, longer battery life, and more accurate heart-rate monitors. But in the last six months, the center of gravity has moved decisively towardintegration: the seamless flow of data from wrist-worn devices, smart rings, and patch sensors into electronic health records (EHRs), clinical trials, and insurer reimbursement workflows.

This week alone, three major announcements underscore the trend.

New Partnerships Bridge Consumer Devices and Clinical Infrastructure

On Tuesday, a leading U.S. health network announced a pilot program with a consumer wearable manufacturer to automatically transmit continuous glucose monitor (CGM) data from a smartwatch companion app directly into its Epic EHR system. The integration is not a simple Bluetooth relay—it involves a new FHIR-based (Fast Healthcare Interoperability Resources) API layer that validates, timestamps, and contextualizes each glucose reading before it enters the patient’s chart. Clinicians will see a trend graph alongside medication lists, with alerts triggered only when readings fall outside a personalized range.

Separately, a European medtech company unveiled a partnership with a major pharmaceutical firm to use a smart ring’s sleep and activity data as a secondary endpoint in a Phase III insomnia trial. The ring’s proprietary algorithm will be audited by an independent data science team, and the raw accelerometer and photoplethysmography (PPG) signals will be stored in a cloud repository accessible to regulatory agencies. This marks one of the first instances where a consumer-grade device, not a medical-grade actigraphy watch, is being used for a pivotal trial endpoint.

Finally, a health insurer in the Asia-Pacific region announced it will begin offering premium discounts to policyholders who share step counts, sleep regularity, and resting heart rate from their existing smart bands—provided the data flows through a certified aggregation platform. The platform strips identifying information before sending summary metrics to the insurer, addressing privacy concerns that have historically stalled such programs.

Why Integration Is Replacing Innovation as the Industry’s Battleground

The rationale for this pivot is clear from recent market data. Global shipments of wearable devices grew only 3.2% year-over-year in Q2 2025, according to a preliminary report from an industry tracker—a sharp deceleration from the double-digit growth seen between 2019 and 2023. Consumer saturation in mature markets, coupled with a lack of compelling new sensor types, has forced manufacturers to look for value beyond the device itself.

At the same time, healthcare providers are facing mounting pressure to adopt value-based care models. Under these models, reimbursements are tied to patient outcomes, not procedure volume. Wearables offer a low-cost, continuous source of physiological data that can help providers monitor chronic conditions like hypertension, diabetes, and heart failure between visits. But the data is only useful if it reaches the right clinician at the right time, in a format that does not add to their alert fatigue.

“The hardware is solved. The integration problem is not,” says Dr. Elena Marsh, a digital health consultant and former chief medical information officer at a large academic medical center. “We have 400 million wearables in circulation, but most of that data lives in silos—inside proprietary apps, on phone storage, or in cloud accounts that no clinician can access. The next five years will be about building the plumbing, not the sensors.”

Marsh points to a critical bottleneck: interoperability standards. While FHIR has become the de facto standard for exchanging clinical data, most wearable manufacturers still use proprietary REST APIs that output data in inconsistent units and time zones. A typical smartwatch can report heart rate in beats per minute, but some also include a “stress score” that is calculated using undisclosed algorithms. Without a common data dictionary, integrating these streams into a clinical decision support system requires significant custom engineering—which is expensive and hard to scale.

Regulatory and Privacy Pressures Shape Integration Strategies

Regulators are also pushing the integration agenda, albeit cautiously. The U.S. Food and Drug Administration (FDA) recently issued draft guidance on “medical device data systems” that clarifies when a wearable manufacturer becomes a medical device manufacturer. The guidance suggests that if a company claims its data can help diagnose or treat a condition, the entire pipeline—sensor, algorithm, and transmission—may fall under regulatory oversight. This has prompted several companies to seek 510(k) clearance for their software algorithms, not just their hardware.

In the European Union, the European Health Data Space (EHDS) regulation, which is expected to be fully implemented by 2027, will require that citizens have access to their own wearable data in a structured, machine-readable format upon request. This is a direct challenge to the closed-ecosystem approach of some large tech companies. A senior policy advisor at the European Commission’s DG SANTE stated in a recent webinar that “wearable data should be treated as a health asset, not a commercial byproduct.”

Privacy concerns remain the largest obstacle to broad integration. A survey conducted by a consumer advocacy group in May found that 68% of U.S. adults are willing to share wearable data with their doctor, but only 22% are willing to share it with an insurance company. The gap reflects fears about risk adjustment, premium hikes, or denial of coverage based on activity trends. To address this, the insurer pilot mentioned earlier uses a “zero-knowledge proof” cryptographic method: the insurer receives only a binary signal (e.g., “meets activity threshold”) without ever seeing raw step counts or heart rate values.

Trends to Watch in the Next 12 Months

Industry analysts expect several developments to accelerate wearable integration:

1. The rise of “wearable gateways” —third-party middleware that normalizes data from multiple devices into a single FHIR-compliant stream. At least four startups have received Series A funding in 2025, and one major EHR vendor has announced a native connector for these gateways.

2. Clinical validation of consumer algorithms —More studies are being published that compare smartwatch PPG-based blood pressure estimates against cuff-based measurements. While no consumer device has yet received FDA clearance for hypertension diagnosis, the data is improving. A meta-analysis released last month showed a mean absolute error of 4.2 mmHg for systolic pressure across six studies—approaching the 5 mmHg threshold considered acceptable for home monitoring devices.

3. Subscription-based integration services —Instead of selling hardware, some companies are shifting to a model where patients pay a monthly fee for continuous remote monitoring, with the wearable provided free. This aligns incentives: the manufacturer is paid for maintaining data flow and algorithm updates, not for selling a new device every two years.

4. Cross-border data portability —The EHDS and similar initiatives in Japan and Canada are forcing device makers to build APIs that can export data in multiple formats. This is a technical burden, but it also creates a moat: companies that comply early will be preferred partners for multinational health systems.

Expert View: Integration Is a Systems Problem, Not a Tech Problem

Dr. Marcus Chen, a cardiologist and director of remote monitoring at a large hospital network in Singapore, offers a pragmatic perspective. “We have seen great success with our heart failure cohort using a simple Bluetooth scale and a step counter. But the integration took 14 months because we had to build custom HL7 interfaces, negotiate data use agreements, and train nurses to interpret the dashboards. The technology was never the issue—it was the workflow redesign.”

Chen argues that the next wave of integration will require collaboration between clinical informaticists, device engineers, and health economists. “We need to show that this data changes decisions. If a wearable alert leads to a medication adjustment that prevents a hospitalization, that’s a measurable outcome. But we need the data infrastructure to prove it.”

As the industry moves forward, the winners will not necessarily be the companies with the most accurate sensor or the sleekest app. They will be the ones that can make their data disappear into the clinical workflow—seamlessly, securely, and with enough context to be actionable. The era of the standalone wearable is ending. The era of the wearable as a node in a larger health information network has begun.